Jul 21, 2026 06:12AM
Aug 15, 2025 07:14AM
Aug 11, 2025 04:15PM
Jul 10, 2025 07:02AM
Jul 10, 2025 07:00AM
Jul 9, 2025 04:01PM
Jul 9, 2025 04:01PM Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
Jul 7, 2025 07:03AM
Jul 7, 2025 07:00AM
Jul 2, 2025 07:01AM
Jul 2, 2025 07:00AM
Jun 30, 2025 07:00AM
Jun 16, 2025 07:00AM
Jun 13, 2025 07:00AM Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
Jun 10, 2025 07:00AM
Jun 5, 2025 07:00AM
May 22, 2025 07:00AM
May 21, 2025 07:00AM
May 21, 2025 07:00AM
May 14, 2025 07:00AM
May 12, 2025 04:30PM Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
Apr 29, 2025 09:05AM
Apr 24, 2025 07:56AM
Apr 24, 2025 07:55AM
Apr 16, 2025 07:00AM
Apr 9, 2025 07:02AM
Apr 9, 2025 07:00AM
Apr 7, 2025 07:00AM Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
Apr 2, 2025 07:00AM
Apr 1, 2025 07:01AM
Apr 1, 2025 07:00AM
Mar 27, 2025 07:00AM
Mar 25, 2025 10:01AM
Mar 24, 2025 08:04AM
Mar 24, 2025 08:00AM Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
Mar 18, 2025 04:30PM
Mar 13, 2025 07:00AM
Mar 11, 2025 07:00AM
Mar 10, 2025 08:00AM
Mar 5, 2025 07:00AM
Mar 4, 2025 07:00AM
Feb 7, 2025 08:33AM Tonix Pharma (TNXP) Reports Prelim FY24 Results
Feb 7, 2025 08:30AM
Feb 6, 2025 08:00AM
Feb 6, 2025 08:00AM
Feb 5, 2025 07:00AM
Feb 4, 2025 07:02AM
Feb 4, 2025 07:00AM
Feb 3, 2025 08:05AM Tonix Pharma (TNXP) Announces 1:100 Reverse Share Split
Feb 3, 2025 08:05AM

15,560 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All